CellCarta

Biofidelity and CellCarta partner to deploy Aspyre® Lung in global clinical trials

9 January 2025 – Cambridge, United Kingdom and Montreal, Canada – Biofidelity, a leader in innovative genomic solutions, and CellCarta, the global contract research organization (CRO) partner of choice for biopharmaceutical companies seeking precision medicine solutions, today announced a strategic partnership agreement to utilize Biofidelity’s Aspyre® Lung in global clinical trials.Aspyre Lung simplifies the detection...
201 President Kennedy Ave., Suite 3900 Montreal, Quebec CANADA H2X 3Y7

+1 (514) 360-3600